APOE and Alzheimer disease: Secondary analyses that replaced the AD-PRS with APOE status (ε4+ versus ε4−) in models 1–5 yielded significantly lower AUCs, suggesting that the predictive utility of the AD-PRS was not driven solely by APOE (Supplementary Table 1).